Shareholding disclosure

Roche Finanz AG

Declared position

9.83%

Threshold

Crossed upwards

Timeline

Published

21.04.2008

Transaction

09.04.2008

Transfer date

09.04.2008

Voting rights breakdown

Voting rights acquired9.83%

Voting rights sold0%

Below threshold0%

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

T6117D5873

Beneficial owner

Roche Finanz AG

Declared address

Roche Finanz AG, Basel

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Roche Finanz AG

Basilea Pharmaceutica AG, Allschwil21.04.2008T6117D5873

Disclosure summary

Roche Finanz AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil on the acquisition side, published by SIX Exchange Regulation on 21.04.2008, at 9.83% of voting rights. Notice category: Group of shareholders.

Disclosed position

9.83%

Voting rights acquired

Voting rights acquired9.83%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Roche Finanz AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil, published on 21.04.2008.

Publication date21.04.2008

Transaction date09.04.2008

Transfer date09.04.2008

Issuing companyBasilea Pharmaceutica AG, Allschwil

Beneficial ownerRoche Finanz AG

Declared addressRoche Finanz AG, Basel

CategoryGroup of shareholders

Voting rights acquired9.83%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDT6117D5873

Commercial register

CHE-103.000.037

Registered

Zefix record

Source: SIX Exchange Regulation · Publication date: 21.04.2008

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open